RNU6-415P

Across TCGA pan-cancer cohorts, RNU6-415P RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated RNU6-415P data layer.

The strongest signal is observed in pancreatic adenocarcinoma (PAAD), where higher RNU6-415P RNA is associated with better overall survival. In most high-consensus cancer types, elevated RNU6-415P expression acts as an unfavorable survival marker, although some lineages such as PAAD and LAML show a favorable association.

PAAD, LAML, and READ are the cancer types where RNU6-415P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PAAD	OS	Quartile	All	0.673	0.295	<.001	89	view →
LAML	DFS	Tertile	All	0.512	0.223	.006	34	view →
READ	DFS	Tertile	II,III,IV	0.932	0.663	.005	31	view →
BRCA	OS	Median	III,IV	0.667	0.425	<.001	23	view →
UVM	DFS	Median	All	0.846	0.615	.034	14	view →
KIRP	DFS	Tertile	III,IV	0.123	0.693	.003	14	view →
SKCM	DFS	Median	All	0.775	0.678	.020	12	view →
UCS	OS	Quartile	All	0.705	0.305	.021	12	view →
PRAD	DFS	Median	All	0.915	0.857	.029	10	view →
DLBC	DFS	Tertile	III,IV	1.000	0.373	.036	9	view →
LIHC	DFS	Median	III,IV	0.531	0.200	.005	7	view →
THYM	OS	Quartile	II,III,IV	1.000	0.602	.007	7	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

RNU6-415P–PAAD (OS)

Open the PAAD breakdown →